Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05775406
Title Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kymera Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
University of California, Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
OU Health Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field